[go: up one dir, main page]

AR025030A1 - USE OF FLUPIRTINE TO RELIEF PAIN IN DEGENERATIVE ARTS IN DOGS AND CATS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SUCH AFFECTIONS - Google Patents

USE OF FLUPIRTINE TO RELIEF PAIN IN DEGENERATIVE ARTS IN DOGS AND CATS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SUCH AFFECTIONS

Info

Publication number
AR025030A1
AR025030A1 ARP000104013A ARP000104013A AR025030A1 AR 025030 A1 AR025030 A1 AR 025030A1 AR P000104013 A ARP000104013 A AR P000104013A AR P000104013 A ARP000104013 A AR P000104013A AR 025030 A1 AR025030 A1 AR 025030A1
Authority
AR
Argentina
Prior art keywords
treatment
flupirtine
cats
dogs
preparation
Prior art date
Application number
ARP000104013A
Other languages
Spanish (es)
Original Assignee
Awd Pharma Gmbh & Co Kg
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Awd Pharma Gmbh & Co Kg, Bayer Ag filed Critical Awd Pharma Gmbh & Co Kg
Publication of AR025030A1 publication Critical patent/AR025030A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se revela la utilizacion de flupirtina o de sus sales de aplicacion terapéutica para el tratamiento de dolores y para la prevencion de una cronificaciondel dolor en el caso de artropatías degenerativas en perros y gatos, que pueden estar acompanadasde inflamaciones. También se describe el uso de laflupirtina, o sus sales de aplicacion terapéutica, para la preparacion de un medicamento para el tratamiento de dichas afecciones.The use of flupirtine or its therapeutic application salts for the treatment of pain and for the prevention of a chronification of pain in the case of degenerative arthropathies in dogs and cats, which may be accompanied by inflammations, is revealed. The use of laflupirtine, or its therapeutic application salts, for the preparation of a medicament for the treatment of such conditions is also described.

ARP000104013A 1999-08-03 2000-08-03 USE OF FLUPIRTINE TO RELIEF PAIN IN DEGENERATIVE ARTS IN DOGS AND CATS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SUCH AFFECTIONS AR025030A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14703399P 1999-08-03 1999-08-03

Publications (1)

Publication Number Publication Date
AR025030A1 true AR025030A1 (en) 2002-11-06

Family

ID=22520069

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104013A AR025030A1 (en) 1999-08-03 2000-08-03 USE OF FLUPIRTINE TO RELIEF PAIN IN DEGENERATIVE ARTS IN DOGS AND CATS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SUCH AFFECTIONS

Country Status (20)

Country Link
EP (1) EP1242078A2 (en)
JP (1) JP2003530308A (en)
KR (1) KR20020040767A (en)
CN (1) CN1399550A (en)
AR (1) AR025030A1 (en)
AU (1) AU7271700A (en)
BR (1) BR0012942A (en)
CA (1) CA2314746A1 (en)
CO (1) CO5180569A1 (en)
CZ (1) CZ2002411A3 (en)
HR (1) HRP20020192A2 (en)
HU (1) HUP0301296A2 (en)
IL (1) IL147667A0 (en)
MX (1) MXPA02000997A (en)
NO (1) NO20020364D0 (en)
PL (1) PL354484A1 (en)
RU (1) RU2002105502A (en)
SK (1) SK1712002A3 (en)
WO (1) WO2001008682A2 (en)
ZA (1) ZA200200493B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10312346A1 (en) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Controlled release system
CA2550023C (en) 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
AU2004298288B2 (en) * 2003-12-16 2011-06-30 Relevare Aust. Pty Ltd Methods and compositions
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
DE102004001558A1 (en) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Medicinal products for topical application in animals
EP1789028A2 (en) * 2004-08-24 2007-05-30 Neuromolecular Pharmaceuticals Inc Compositions for treating nociceptive pain
KR101067443B1 (en) * 2009-06-23 2011-09-27 여오영 Topical injectable compositions for the treatment of hemorrhoids containing hydroxychloroquine
ITMI20120896A1 (en) * 2012-05-23 2013-11-24 Bongulielmi Reto CONDROITIN FOR USE IN MEDICINE
CN104523634A (en) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 Flupirtine maleate sustained release tablet and preparation method thereof
RU2680244C1 (en) * 2017-12-28 2019-02-19 Общество С Ограниченной Ответственностью "Валента-Интеллект" Combination of flupirtine and cyclobenzaprine for treatment of pain syndromes
CN111371527B (en) 2018-12-25 2021-08-13 华为技术有限公司 A data transmission method and communication device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189788B1 (en) * 1985-01-23 1989-09-13 ASTA Pharma Aktiengesellschaft Synergistic combination of flupirtin and non-steroidal anti-phlogistics
FI855016A7 (en) * 1985-06-28 1986-12-29 Degussa Synergistic combination of flupirtine and 4-acetamido-phenol.
IN172468B (en) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4236752A1 (en) * 1992-10-30 1994-05-05 Asta Medica Ag Combination preparation of flupirtine and morphine for the treatment of pain and for avoiding morphine addiction

Also Published As

Publication number Publication date
RU2002105502A (en) 2004-03-20
WO2001008682A2 (en) 2001-02-08
IL147667A0 (en) 2002-08-14
WO2001008682A3 (en) 2002-07-18
PL354484A1 (en) 2004-01-26
HRP20020192A2 (en) 2004-02-29
CZ2002411A3 (en) 2003-03-12
CO5180569A1 (en) 2002-07-30
HUP0301296A2 (en) 2003-08-28
SK1712002A3 (en) 2003-03-04
BR0012942A (en) 2002-07-09
NO20020364L (en) 2002-01-23
KR20020040767A (en) 2002-05-30
MXPA02000997A (en) 2003-10-14
NO20020364D0 (en) 2002-01-23
ZA200200493B (en) 2003-04-30
CA2314746A1 (en) 2001-02-03
CN1399550A (en) 2003-02-26
JP2003530308A (en) 2003-10-14
AU7271700A (en) 2001-02-19
EP1242078A2 (en) 2002-09-25

Similar Documents

Publication Publication Date Title
ES2072447T3 (en) EXTERNAL ANALGESIC LOTION AND PREPARATION PROCEDURE.
ES2152485T3 (en) PROCEDURE TO PREPARE TABLETS CONTAINING AMOXYCLINE AND CLAVULANATE COVERED BY A WATERPROOF POLYMERIC FILM.
ES2147294T3 (en) THERAPEUTIC COMPOUNDS.
AR003984A1 (en) ANTIPRURITICAL, COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS, PROCEDURE FOR ITS PREPARATION AND USE OF SUCH COMPOSITIONS TO OBTAIN A MEDICATION.
BR9406363A (en) Pharmaceutical composition process for the preparation of the same use and process for the treatment of diseases related to gastric acid
MX9300904A (en) COMPOSITIONS CONTAINING HYALURONIC ACID
MX9301929A (en) DERIVATIVES OF PIRIMIDINE AND PROCEDURES FOR ITS PREPARATION.
AR005282A1 (en) ORAL PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET OF MULTIPLE UNITS, USE OF THE SAME FOR THE PREPARATION OF MEDICINES, AND PROCEDURE FOR ITS MANUFACTURE.
ES2125380T3 (en) MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR MEDICINES AT VERY LOW DOSE, ESPECIALLY HOMEOPATHIC MEDICINES.
ES2156840T1 (en) MEDICINAL PRODUCT CONTAINING PENTOSANE POLYSULFATE AND IMPLANT TO TREAT FIBROSIS.
ES2139132T3 (en) PHARMACEUTICAL COMPOSITIONS ACTIVE IN SLEEP DISORDERS THERAPY.
AR025030A1 (en) USE OF FLUPIRTINE TO RELIEF PAIN IN DEGENERATIVE ARTS IN DOGS AND CATS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SUCH AFFECTIONS
ES2130152T3 (en) MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE.
DK0574255T3 (en) New derivatives of non-steroidal anti-inflammatory analgesic and / or antipyretic drugs, their use and pharmaceutical formulations containing them.
ES2170813T3 (en) 2,2-DICHLOROALCANOCARBOXILIC ACIDS, PROCESS FOR THEIR PREPARATION, MEDICINES CONTAINING THEM AND THEIR USE TO TREAT INSULIN RESISTANCE.
ES2129485T3 (en) DERIVATIVES OF GUANIDINOALKYL-1,1-BISPHOSPHONIC ACIDS, PROCEDURE FOR THEIR PREPARATION AND USE.
BR9916114A (en) Use of apomorphine in the manufacture of a medicament for treating male organic erectile dysfunction
ES2033682T3 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING ACID 2- (2-FLUORO-4-BIPHENYLIL) OR ONE OF ITS SALTS.
AR006401A1 (en) PIRROLOPYROLONE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND IN THERAPY, PROCESSES FOR ITS PREPARATION AND INTERMEDIARY COMPOUNDS FOR SUCH PROCESSES.
MX9206976A (en) AGROCHEMICAL COMPOSITION FOR THE PROTECTION OF PLANTS AGAINST THE DISEASES OF THE SAME AND; PHYTOPHAGUS INSECTS.
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
ES2087623T3 (en) DERIVATIVES OF BENCIMIDAZOLE AS AN ANTIMICROBIAL AGENT AGAINST CAMPYLOBACTER PYLON.
ES2167385T3 (en) ANTIHIPERGLICEMIC ACTION DRUGS.
ES2159357T3 (en) TERPENOID DERIVATIVES (SARCODICTINES) USEFUL AS ANTITUMOR AGENTS.
ES2059869T3 (en) PHARMACEUTICAL PREPARATION CONTAINING PIROXICAM FOR TOPICAL USE.

Legal Events

Date Code Title Description
FB Suspension of granting procedure